Your request to link to rcsb for GRIA2
- 1FTJ: crystal structure of the glur2 ligand binding core (s1s2j) in complex with glutamate at 1.9 resolution (10.1016/S0896-6273(00)00094-5 )
- 1FTK: crystal structure of the glur2 ligand binding core (s1s2i) in complex with kainate at 1.6 a resolution (10.1016/S0896-6273(00)00094-5 )
- 1FTL: crystal structure of the glur2 ligand binding core (s1s2j) in complex with the antagonist dnqx at 1.8 a resolution (10.1016/S0896-6273(00)00094-5 )
- 1FTM: crystal structure of the glur2 ligand binding core (s1s2j) in complex with ampa at 1.7 resolution (10.1016/S0896-6273(00)00094-5 )
- 1FTO: crystal structure of the glur2 ligand binding core (s1s2j) in the apo state at 2.0 a resolution (10.1016/S0896-6273(00)00094-5 )
- 1FW0: crystal structure of the glur2 ligand binding core (s1s2j) in complex with kainate at 2.0 a resolution (10.1016/S0896-6273(00)00094-5 )
- 1GR2: structure of a glutamate receptor ligand binding core (glur2) complexed with kainate (10.1038/27692 )
- 1LB8: crystal structure of the non-desensitizing glur2 ligand binding core mutant (s1s2j-l483y) in complex with ampa at 2.3 resolution (10.1038/417245A )
- 1LB9: crystal structure of the non-desensitizing glur2 ligand binding core mutant (s1s2j-l483y) in complex with antagonist dnqx at 2.3 a resolution (10.1038/417245A )
- 1LBB: crystal structure of the glur2 ligand binding domain mutant (s1s2j- n754d) in complex with kainate at 2.1 a resolution (10.1038/417245A )
- 1LBC: crystal structure of glur2 ligand binding core (s1s2j- n775s) in complex with cyclothiazide (ctz) as well as glutamate at 1.8 a resolution (10.1038/417245A )
- 1M5B: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with 2-me-tet-ampa at 1.85 a resolution. (10.1016/S0022-2836(02)00650-2 )
- 1M5C: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with br-hibo at 1.65 a resolution (10.1016/S0022-2836(02)00650-2 )
- 1M5D: x-ray structure of the glur2 ligand binding core (s1s2j-y702f) in complex with br-hibo at 1.73 a resolution (10.1016/S0022-2836(02)00650-2 )
- 1M5E: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with acpa at 1.46 a resolution (10.1016/S0022-2836(02)00650-2 )
- 1M5F: x-ray structure of the glur2 ligand binding core (s1s2j-y702f) in complex with acpa at 1.95 a resolution (10.1016/S0022-2836(02)00650-2 )
- 1MM6: crystal structure of the glur2 ligand binding core (s1s2j) in complex with quisqualate in a non zinc crystal form at 2.15 angstroms resolution (10.1021/BI020583K )
- 1MM7: crystal structure of the glur2 ligand binding core (s1s2j) in complex with quisqualate in a zinc crystal form at 1.65 angstroms resolution (10.1021/BI020583K )
- 1MQD: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-des-me-ampa at 1.46 a resolution. crystallization in the presence of lithium sulfate. (10.1016/S0014-5793(02)03496-8 )
- 1MQG: crystal structure of the glur2 ligand binding core (s1s2j) in complex with iodo-willardiine at 2.15 angstroms resolution (10.1038/NN1091 )
- 1MQH: crystal structure of the glur2 ligand binding core (s1s2j) in complex with bromo-willardiine at 1.8 angstroms resolution (10.1038/NN1091 )
- 1MQI: crystal structure of the glur2 ligand binding core (s1s2j) in complex with fluoro-willardiine at 1.35 angstroms resolution (10.1038/NN1091 )
- 1MQJ: crystal structure of the glur2 ligand binding core (s1s2j) in complex with willardiine at 1.65 angstroms resolution (10.1038/NN1091 )
- 1MS7: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-des-me-ampa at 1.97 a resolution, crystallization in the presence of zinc acetate (10.1016/S0014-5793(02)03496-8 )
- 1MXU: crystal structure of the glur2 ligand binding core (s1s2j) in complex with bromo-willardiine (control for the crystal titration experiments) (10.1021/BI020632T )
- 1MXV: crystal titration experiments (ampa co-crystals soaked in 10 mm brw) (10.1021/BI020632T )
- 1MXW: crystal titration experiments (ampa co-crystals soaked in 1 mm brw) (10.1021/BI020632T )
- 1MXX: crystal titration experiments (ampa co-crystals soaked in 100 um brw) (10.1021/BI020632T )
- 1MXY: crystal titration experiments (ampa co-crystals soaked in 10 um brw) (10.1021/BI020632T )
- 1MXZ: crystal titration experiments (ampa co-crystals soaked in 1 um brw) (10.1021/BI020632T )
- 1MY0: crystal titration experiments (ampa co-crystals soaked in 100 nm brw) (10.1021/BI020632T )
- 1MY1: crystal titration experiments (ampa co-crystals soaked in 10 nm brw) (10.1021/BI020632T )
- 1MY2: crystal titration experiment (ampa complex control) (10.1021/BI020632T )
- 1MY3: crystal structure of glutamate receptor ligand-binding core in complex with bromo-willardiine in the zn crystal form (10.1021/BI020632T )
- 1MY4: crystal structure of glutamate receptor ligand-binding core in complex with iodo-willardiine in the zn crystal form (10.1021/BI020632T )
- 1N0T: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with the antagonist (s)-atpo at 2.1 a resolution. (10.1021/JM020989V )
- 1NNK: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-atpa at 1.85 a resolution. crystallization with zinc ions. (10.1021/JM021020+ )
- 1NNP: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-atpa at 1.9 a resolution. crystallization without zinc ions. (10.1021/JM021020+ )
- 1P1N: glur2 ligand binding core (s1s2j) mutant l650t in complex with kainate (10.1073/PNAS.1037393100 )
- 1P1O: crystal structure of the glur2 ligand-binding core (s1s2j) mutant l650t in complex with quisqualate (10.1073/PNAS.1037393100 )
- 1P1Q: crystal structure of the glur2 ligand binding core (s1s2j) l650t mutant in complex with ampa (10.1073/PNAS.1037393100 )
- 1P1U: crystal structure of the glur2 ligand-binding core (s1s2j) l650t mutant in complex with ampa (ammonium sulfate crystal form) (10.1073/PNAS.1037393100 )
- 1P1W: crystal structure of the glur2 ligand-binding core (s1s2j) with the l483y and l650t mutations and in complex with ampa (10.1073/PNAS.1037393100 )
- 1SYH: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-cpw399 at 1.85 a resolution. (10.1124/MOL.104.002931 )
- 1SYI: x-ray structure of the y702f mutant of the glur2 ligand- binding core (s1s2j) in complex with (s)-cpw399 at 2.1 a resolution. (10.1124/MOL.104.002931 )
- 1WVJ: exploring the glur2 ligand-binding core in complex with the bicyclic ampa analogue (s)-4-ahcp (10.1111/J.1742-4658.2005.04583.X )
- 1XHY: x-ray structure of the y702f mutant of the glur2 ligand-binding core (s1s2j) in complex with kainate at 1.85 a resolution (10.1124/MOL.104.002931 )
- 2AIX: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-thio-atpa at 2.2 a resolution.
- 2AL4: crystal structure of the glur2 ligand binding core (s1s2j) in complex with quisqualate and cx614. (10.1523/JNEUROSCI.2567-05.2005 )
- 2AL5: crystal structure of the glur2 ligand binding core (s1s2j) in complex with fluoro-willardiine and aniracetam (10.1523/JNEUROSCI.2567-05.2005 )
- 2ANJ: crystal structure of the glur2 ligand binding core (s1s2j-y450w) mutant in complex with the partial agonist kainic acid at 2.1 a resolution (10.1074/JBC.M507800200 )
- 2CMO: the structure of a mixed glur2 ligand-binding core dimer in complex with (s)-glutamate and the antagonist (s)-ns1209 03-jul-06 2cmo 1 title (10.1016/J.JMB.2006.01.024 )
- 2GFE: crystal structure of the glur2 a476e s673d ligand binding core mutant at 1.54 angstroms resolution (10.1523/JNEUROSCI.1519-06.2006 )
- 2I3V: measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: structure of g725c mutant (10.1016/J.CELL.2006.08.037 )
- 2I3W: measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: structure of s729c mutant (10.1016/J.CELL.2006.08.037 )
- 2P2A: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with 2-bn-tet-ampa at 2.26a resolution (10.1021/JM061439Q )
- 2UXA: crystal structure of the glur2-flip ligand binding domain, r/g unedited. (10.1016/J.NEURON.2006.05.020 )
- 2WJW: crystal structure of the human ionotropic glutamate receptor glur2 atd region at 1.8 a resolution 25-aug-09 2wjw 1 title (10.1016/J.JMB.2009.07.082 )
- 2WJX: crystal structure of the human ionotropic glutamate receptor glur2 atd region at 4.1 a resolution 25-aug-09 2wjx 1 title (10.1016/J.JMB.2009.07.082 )
- 2XHD: crystal structure of n-((2s)-5-(6-fluoro-3-pyridinyl)-2,3- dihydro-1h-inden-2-yl)-2-propanesulfonamide in complex with the ligand binding domain of the human glua2 receptor (10.1021/JM1005429 )
- 2XX7: crystal structure of 1-(4-(1-pyrrolidinylcarbonyl)phenyl)-3- (trifluoromethyl)-4,5,6,7-tetrahydro-1h-indazole in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 2.2a resolution. (10.1021/JM100679E )
- 2XX8: crystal structure of n,n-dimethyl-4-(3-(trifluoromethyl)-4, 5,6,7-tetrahydro-1h-indazol-1-yl)benzamide in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 2.2a resolution. (10.1021/JM100679E )
- 2XX9: crystal structure of 1-((2-fluoro-4-(3-(trifluoromethyl)-4,5,6,7- tetrahydro-1h-indazol-1-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 2.2a resolution. (10.1021/JM100679E )
- 2XXH: crystal structure of 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)phenyl)-3- (trifluoromethyl)-4,5,6,7-tetrahydro-1h-indazole in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 1.5a resolution. (10.1021/JM100679E )
- 2XXI: crystal structure of 1-((4-(3-(trifluoromethyl)-6,7-dihydropyrano(4,3 -c(pyrazol-1(4h)-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 1.6a resolution. (10.1021/JM100679E )
- 3B6Q: crystal structure of the glur2 ligand binding core (s1s2j) mutant t686a in complex with glutamate at 2.0 resolution (10.1523/JNEUROSCI.3309-07.2008 )
- 3B6T: crystal structure of the glur2 ligand binding core (s1s2j) t686a mutant in complex with quisqualate at 2.1 resolution (10.1523/JNEUROSCI.3309-07.2008 )
- 3B6W: crystal structure of the glur2 ligand binding core (s1s2j) t686s mutant in complex with glutamate at 1.7 resolution (10.1523/JNEUROSCI.3309-07.2008 )
- 3B7D: crystal structure of the glur2 ligand binding core (hs1s2j) in complex with cnqx at 2.5 a resolution (10.1126/SCIENCE.1146317 )
- 3BBR: crystal structure of the iglur2 ligand binding core (s1s2j-n775s) in complex with a dimeric positive modulator as well as glutamate at 2.25 a resolution (10.1016/J.CHEMBIOL.2007.10.012 )
- 3BFT: structure of the ligand-binding core of glur2 in complex with the agonist (s)-tdpa at 2.25 a resolution (10.1021/JM701126W )
- 3BFU: structure of the ligand-binding core of glur2 in complex with the agonist (r)-tdpa at 1.95 a resolution (10.1021/JM701126W )
- 3BKI: crystal structure of the glur2 ligand binding core (s1s2j) in complex with fqx at 1.87 angstroms (10.1021/JM701517B )
- 3DP6: crystal structure of the binding domain of the ampa subunit glur2 bound to glutamate (10.1002/PROT.22274 )
- 3EN3: crystal structure of the glur4 ligand-binding domain in complex with kainate (10.1021/BI8013196 )
- 3EPE: crystal structure of the glur4 ligand-binding domain in complex with glutamate (10.1021/BI8013196 )
- 3H03: crystal structure of the binding domain of the ampa subunit glur2 bound to ubp277 (10.1021/BI900107M )
- 3H06: crystal structure of the binding domain of the ampa subunit glur2 bound to the willardiine antagonist, ubp282 (10.1021/BI900107M )
- 3H5V: crystal structure of the glur2-atd (10.1038/EMBOJ.2009.140 )
- 3H5W: crystal structure of the glur2-atd in space group p212121 without solvent (10.1038/EMBOJ.2009.140 )
- 3H6T: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and cyclothiazide at 2.25 a resolution (10.1016/J.JMB.2009.07.002 )
- 3H6U: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and ns1493 at 1.85 a resolution (10.1016/J.JMB.2009.07.002 )
- 3H6V: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and ns5206 at 2.10 a resolution (10.1016/J.JMB.2009.07.002 )
- 3H6W: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and ns5217 at 1.50 a resolution (10.1016/J.JMB.2009.07.002 )
- 3HSY: high resolution structure of a dimeric glur2 n-terminal domain (ntd) (10.1038/EMBOJ.2011.16 )
- 3IJO: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, althiazide (10.1021/BI901127S )
- 3IJX: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, hydrochlorothiazide (10.1021/BI901127S )
- 3IK6: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, chlorothiazide (10.1021/BI901127S )
- 3IL1: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, idra-21 (10.1021/BI901127S )
- 3ILT: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, trichlormethiazide (10.1021/BI901127S )
- 3ILU: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, hydroflumethiazide (10.1021/BI901127S )
- 3KEI: crystal structure of the glua4 ligand-binding domain l651v mutant in complex with glutamate (10.1523/JNEUROSCI.4558-09.2010 )
- 3KFM: crystal structure of the glua4 ligand-binding domain l651v mutant in complex with kainate (10.1523/JNEUROSCI.4558-09.2010 )
- 3KG2: ampa subtype ionotropic glutamate receptor in complex with competitive antagonist zk 200775 (10.1038/NATURE08624 )
- 3KGC: isolated ligand binding domain dimer of glua2 ionotropic glutamate receptor in complex with glutamate, ly 404187 and zk 200775
- 3LSF: piracetam bound to the ligand binding domain of glua2 (10.1021/JM901905J )
- 3LSL: piracetam bound to the ligand binding domain of glua2 (flop form) (10.1021/JM901905J )
- 3LSW: aniracetam bound to the ligand binding domain of glua3 (10.1021/JM901905J )
- 3LSX: piracetam bound to the ligand binding domain of glua3 (10.1021/JM901905J )
- 3M3F: pepa bound to the ligand binding domain of glua3 (flop form) (10.1021/BI1000678 )
- 3M3K: ligand binding domain (s1s2) of glua3 (flop) (10.1021/BI1000678 )
- 3M3L: pepa bound to the ligand binding domain of glua2 (flop form) (10.1021/BI1000678 )
- 3N6V: structure of the glua2 ntd-dimer interface mutant, t78a (10.1038/EMBOJ.2011.16 )
- 3O28: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.07.138 )
- 3O29: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.07.138 )
- 3O2A: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.07.138 )
- 3O2J: structure of the glua2 ntd-dimer interface mutant, n54a (10.1038/EMBOJ.2011.16 )
- 3O6G: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.08.063 )
- 3O6H: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.08.063 )
- 3O6I: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.08.063 )
- 3PD8: x-ray structure of the ligand-binding core of glua2 in complex with (s)-7-hpca at 2.5 a resolution (10.1021/JM101218A )
- 3PD9: x-ray structure of the ligand-binding core of glua2 in complex with (r)-5-hpca at 2.1 a resolution (10.1021/JM101218A )
- 3PMV: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.11.098 )
- 3PMW: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.11.098 )
- 3PMX: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.BMCL.2010.11.098 )
- 3R7X: crystal structure analysis of a quinazolinedione sulfonamide bound to human glur2: a novel class of competitive ampa receptor antagonists with oral activity (10.1016/J.BMCL.2011.04.017 )
- 3RN8: crystal structure of iglur2 ligand binding domain and symmetrical carboxyl containing potentiator (10.1124/MOL.110.070243 )
- 3RNN: crystal structure of iglur2 ligand binding domain with symmetric sulfonamide containing potentiator (10.1124/MOL.110.070243 )
- 3RT6: fluorowillardiine bound to the ligand binding domain of glua3 (10.1124/MOL.111.071688 )
- 3RT8: chlorowillardiine bound to the ligand binding domain of glua3 (10.1124/MOL.111.071688 )
- 3RTF: chlorowillardiine bound to the ligand binding domain of glua2 (10.1124/MOL.111.071688 )
- 3RTW: nitrowillardiine bound to the ligand binding domain of glua2 (10.1124/MOL.111.071688 )
- 3T93: glutamate bound to a double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
- 3T96: iodowillardiine bound to a double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
- 3T9H: kainate bound to a double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
- 3T9U: cnqx bound to an oxidized double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
- 3T9V: cnqx bound to a reduced double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
- 3T9X: glutamate bound to a double cysteine mutant (v484c/e657c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
- 3TDJ: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam-97 at 1.95 a resolution (10.1042/BJ20111221 )
- 3TKD: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and cyclothiazide at 1.45 a resolution (10.1042/BJ20111221 )
- 3TZA: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (s)-2-amino-3-(2-(2-carboxyethyl)-5- chloro-4-nitrophenyl)propionic acid at 1.9a resolution (10.1021/JM200862H )
- 3UA8: crystal structure analysis of a 6-amino quinazolinedione sulfonamide bound to human glur2 (10.1016/J.BMCL.2011.12.009 )
- 4F1Y: cnqx bound to the ligand binding domain of glua3 (10.1021/BI3001837 )
- 4F22: kainate bound to the k660a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
- 4F29: quisqualate bound to the ligand binding domain of glua3i (10.1021/BI3001837 )
- 4F2O: quisqualate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
- 4F2Q: quisqualate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
- 4F31: kainate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
- 4F39: kainate bound to the ligand binding domain of glua3 (10.1021/BI3001837 )
- 4F3B: glutamate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
- 4F3G: kainate bound to the ligand binding domain of glua3i (10.1021/BI3001837 )
- 4FAT: ligand-binding domain of glua2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator (10.1016/J.NEUROPHARM.2012.06.008 )
- 4G8M: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the agonist cbg-iv at 2.05a resolution (10.1016/J.JSB.2012.07.001 )
- 4GXS: ligand binding domain of glua2 (ampa/glutamate receptor) bound to (-)- kaitocephalin (10.1074/JBC.M112.416362 )
- 4H8J: structure of glua2-lbd in complex with mes
- 4IGT: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the agonist za302 at 1.24a resolution (10.1021/JM301433M )
- 4ISU: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (2r)-ikm-159 at 2.3a resolution. (10.1021/JM301590Z )
- 4IY5: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and cx516 at 2.0 a resolution (10.1107/S0907444913011839 )
- 4IY6: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and me-cx516 at 1.72 a resolution (10.1107/S0907444913011839 )
- 4L17: glua2-l483y-a665c ligand-binding domain in complex with the antagonist dnqx (10.1016/J.NEURON.2013.06.003 )
- 4LZ5: crystal structures of glur2 ligand-binding-domain in complex with glutamate and positive allosteric modulators (10.1021/JM401274B )
- 4LZ7: crystal structures of glur2 ligand-binding-domain in complex with glutamate and positive allosteric modulators (10.1021/JM401274B )
- 4LZ8: crystal structures of glur2 ligand-binding-domain in complex with glutamate and positive allosteric modulators (10.1021/JM401274B )
- 4N07: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam-344 at 1.87 a resolution (10.1021/JM4012092 )
- 4O3A: crystal structure of the glua2 ligand-binding domain in complex with l-aspartate at 1.80 a resolution 14-dec-16 4o3a 1 title (10.1111/FEBS.12795 )
- 4O3B: crystal structure of an open/closed glua2 ligand-binding domain dimer at 1.91 a resolution (10.1111/FEBS.12795 )
- 4O3C: crystal structure of the glua2 ligand-binding domain in complex with l-aspartate at 1.50 a resolution 14-dec-16 4o3c 1 title (10.1111/FEBS.12795 )
- 4Q30: nitrowillardiine bound to the ligand binding domain of glua2 at ph 3.5 (10.1021/BI500511M )
- 4U1O: glua2flip slbd complexed with kainate and (r,r)-2b crystal form c (10.1016/J.CELL.2014.07.023 )
- 4U1W: full length glua2-kainate-(r,r)-2b complex crystal form a (10.1016/J.CELL.2014.07.023 )
- 4U1X: full length glua2-kainate-(r,r)-2b complex crystal form b (10.1016/J.CELL.2014.07.023 )
- 4U1Y: full length glua2-fw-(r,r)-2b complex (10.1016/J.CELL.2014.07.023 )
- 4U1Z: glua2flip slbd complexed with kainate and (r,r)-2b crystal form d (10.1016/J.CELL.2014.07.023 )
- 4U21: glua2flip slbd complexed with fw and (r,r)-2b crystal form e (10.1016/J.CELL.2014.07.023 )
- 4U22: glua2flip slbd complexed with fw and (r,r)-2b crystal form d (10.1016/J.CELL.2014.07.023 )
- 4U23: glua2flip slbd complexed with fw and (r,r)-2b crystal form f (10.1016/J.CELL.2014.07.023 )
- 4U2P: full-length ampa subtype ionotropic glutamate receptor glua2 in the apo state (10.1016/J.CELL.2014.07.023 )
- 4U2Q: full-length ampa subtype ionotropic glutamate receptor glua2 in complex with partial agonist kainate (10.1016/J.CELL.2014.07.023 )
- 4U2R: crystal structure of the glur2 ligand binding core (s1s2j, flip variant) in the apo state (10.1016/J.CELL.2014.07.023 )
- 4U4F: structure of glua2* in complex with partial agonist (s)-5- nitrowillardiine (10.1126/SCIENCE.1256508 )
- 4U4G: structure of glua2* in complex with competitive antagonist zk 200775 (10.1126/SCIENCE.1256508 )
- 4U4S: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam25 at 1.90 a resolution. (10.1021/JM501268R )
- 4U4X: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam37 at 1.56 a resolution. (10.1021/JM501268R )
- 4U5B: crystal structure of glua2 a622t, con-ikot-ikot snail toxin, partial agonist ka and postitive modulator (r,r)-2b complex (10.1126/SCIENCE.1258409 )
- 4U5C: crystal structure of glua2, con-ikot-ikot snail toxin, partial agonist fw and postitive modulator (r,r)-2b complex (10.1126/SCIENCE.1258409 )
- 4U5D: crystal structure of glua2, con-ikot-ikot snail toxin, partial agonist ka and postitive modulator (r,r)-2b complex (10.1126/SCIENCE.1258409 )
- 4U5E: crystal structure of glua2 t625g, con-ikot-ikot snail toxin, partial agonist ka and postitive modulator (r,r)-2b complex (10.1126/SCIENCE.1258409 )
- 4U5F: crystal structure of glua2, con-ikot-ikot snail toxin, partial agonist ka and postitive modulator (r,r)-2b complex, glua2cryst2 construct (10.1126/SCIENCE.1258409 )
- 4UQ6: electron density map of glua2em in complex with ly451646 and glutamate (10.1038/NATURE13603 )
- 4UQJ: cryo-em density map of glua2em in complex with zk200775 (10.1038/NATURE13603 )
- 4UQK: electron density map of glua2em in complex with quisqualate and ly451646 (10.1038/NATURE13603 )
- 4X48: crystal structure of glur2 ligand-binding core (10.1021/ACS.JMEDCHEM.5B00300 )
- 4YMA: structure of the ligand-binding domain of glua2 in complex with the antagonist cng10109 (10.1021/ACS.JMEDCHEM.5B00750 )
- 4YU0: crystal structure of a tetramer of glua2 tr mutant ligand binding domains bound with glutamate at 1.26 angstrom resolution
- 4Z0I: crystal structure of a tetramer of glua2 ligand binding domains bound with glutamate at 1.45 angstrom resolution
- 5BUU: crystal structure of the glua2 ligand-binding domain (l483y-n754s) in complex with glutamate and bpam-321 at 2.07 a resolution (10.1021/ACSCHEMNEURO.5B00318 )
- 5CBR: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (s)-2-amino-3-(3,4-dichloro-5-(5- hydroxypyridin-3-yl)phenyl)propanoic acid at 2.0a resolution (10.1021/ACS.JMEDCHEM.5B01666 )
- 5CBS: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (r)-2-amino-3-(3'-hydroxybiphenyl-3-yl) propanoic acid at 1.8a resolution (10.1021/ACS.JMEDCHEM.5B01666 )
- 5ELV: crystal structure of the glua2 ligand-binding domain (s1s2j-l504-n775) in complex with glutamate and bpam-521 at 1.92 a resolution (10.1016/J.BPJ.2016.04.032 )
- 5FHM: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with (s)-2-amino-3-(5-(2-(3-(aminomethyl)benzyl)-2h-tetrazol- 5-yl)-3-hydroxyisoxazol-4-yl)propanoic acid at resolution 1.55 a resolution (10.1021/ACS.JMEDCHEM.5B01982 )
- 5FHN: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with (s)-2-amino-3-(5-(2-(3-methylbenzyl)-2h-tetrazol-5-yl)- 3-hydroxyisoxazol-4-yl)propanoic acid at 1.6 a resolution (10.1021/ACS.JMEDCHEM.5B01982 )
- 5FHO: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with (s)-2-amino-3-(5-(2-(3-chlorobenzyl)-2h-tetrazol-5-yl)- 3-hydroxyisoxazol-4-yl)propanoic acid at 2.3 a resolution (10.1021/ACS.JMEDCHEM.5B01982 )
- 5FTH: crystal structure of the glua2 k738m-t744k lbd in complex with glutamate (zinc form) (10.1016/J.NEURON.2016.01.038 )
- 5FTI: crystal structure of the glua2 k738m-t744k lbd in complex with glutamate (lithium form) (10.1016/J.NEURON.2016.01.038 )
- 5FWX: crystal structure of the ampa receptor glua2/a4 n-terminal domain heterodimer (10.1126/SCIENCE.AAD3873 )
- 5FWY: crystal structure of the ampa receptor glua2/a3 n-terminal domain heterodimer (10.1126/SCIENCE.AAD3873 )
- 5H8S: structure of the human glua2 lbd in complex with gne3419 (10.1016/J.NEURON.2016.01.016 )
- 5IDE: cryo-em structure of glua2/3 ampa receptor heterotetramer (model i) (10.1126/SCIENCE.AAD3873 )
- 5IDF: cryo-em structure of glua2/3 ampa receptor heterotetramer (model ii) (10.1126/SCIENCE.AAD3873 )
- 5JEI: crystal structure of the glua2 lbd in complex with fw (10.1038/NCOMMS14327 )
- 5KBS: cryo-em structure of glua2-0xstz at 8.7 angstrom resolution (10.1126/SCIENCE.AAF8411 )
- 5KBT: cryo-em structure of glua2-1xstz complex at 6.4 angstrom resolution (10.1126/SCIENCE.AAF8411 )
- 5KBU: cryo-em structure of glua2-2xstz complex at 7.8 angstrom resolution (10.1126/SCIENCE.AAF8411 )
- 5KBV: cryo-em structure of glua2 bound to antagonist zk200775 at 6.8 angstrom resolution (10.1126/SCIENCE.AAF8411 )
- 5KK2: architecture of fully occupied glua2 ampa receptor - tarp complex elucidated by single particle cryo-electron microscopy (10.1038/NATURE18961 )
- 5L1B: ampa subtype ionotropic glutamate receptor glua2 in apo state (10.1016/J.NEURON.2016.08.012 )
- 5L1E: ampa subtype ionotropic glutamate receptor glua2 in complex with noncompetitive inhibitor cp465022 (10.1016/J.NEURON.2016.08.012 )
- 5L1F: ampa subtype ionotropic glutamate receptor glua2 in complex with noncompetitive inhibitor perampanel (10.1016/J.NEURON.2016.08.012 )
- 5L1G: ampa subtype ionotropic glutamate receptor glua2 in complex with gyki- br (10.1016/J.NEURON.2016.08.012 )
- 5L1H: ampa subtype ionotropic glutamate receptor glua2 in complex with noncompetitive inhibitor gyki53655 (10.1016/J.NEURON.2016.08.012 )
- 5N6P: ampa receptor ntd mutant
- 5NG9: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with agonist cip-as at 1.15 a resolution. (10.1021/ACSCHEMNEURO.7B00201 )
- 5NIH: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with agonist lm-12b at 1.3 a resolution. (10.1021/ACSCHEMNEURO.7B00201 )
- 5NS9: crystal structure of the glua2 lbd (l483y-n754s-l758v) in complex with glutamate (10.1016/J.BPJ.2017.07.030 )
- 5O9A: crystal structure of the glua2 ligand-binding domain (s1s2j-l504y- n775s) in complex with glutamate and bpam121 at 1.78 a resolution (10.1021/ACS.JMEDCHEM.7B01323 )
- 5OEW: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with glutamate and positive allosteric modulator bpam538 (10.1021/ACS.JMEDCHEM.7B01323 )
- 5VHW: glua2-0xgsg1l bound to zk (10.1016/J.NEURON.2017.04.025 )
- 5VHX: glua2-1xgsg1l bound to zk (10.1016/J.NEURON.2017.04.025 )
- 5VHY: glua2-2xgsg1l bound to zk (10.1016/J.NEURON.2017.04.025 )
- 5VHZ: glua2-2xgsg1l bound to l-quisqualate (10.1016/J.NEURON.2017.04.025 )
- 5VOT: structure of ampa receptor-tarp complex (10.1016/J.CELL.2017.07.045 )
- 5VOU: structure of ampa receptor-tarp complex (10.1016/J.CELL.2017.07.045 )
- 5VOV: structure of ampa receptor-tarp complex (10.1016/J.CELL.2017.07.045 )
- 5WEK: glua2 bound to antagonist zk and gsg1l in digitonin, state 1 (10.1038/NATURE23479 )
- 5WEL: glua2 bound to antagonist zk and gsg1l in digitonin, state 2 (10.1038/NATURE23479 )
- 5WEM: glua2 bound to gsg1l in digitonin, state 1 (10.1038/NATURE23479 )
- 5WEN: glua2 bound to gsg1l in digitonin, state 2 (10.1038/NATURE23479 )
- 5WEO: activated glua2 complex bound to glutamate, cyclothiazide, and stz in digitonin (10.1038/NATURE23479 )
- 5YBF: crystal structure of the glua2o lbd in complex with glutamate and hbt1 (10.1124/JPET.117.245050 )
- 5YBG: crystal structure of the glua2o lbd in complex with glutamate and ly451395 (10.1124/JPET.117.245050 )
- 5ZG0: crystal structure of the glua2o lbd in complex with glutamate and compound-1 (10.1038/S41386-018-0213-7 )
- 5ZG1: crystal structure of the glua2o lbd in complex with glutamate and compound-2 (10.1038/S41386-018-0213-7 )
- 5ZG2: crystal structure of the glua2o lbd in complex with zk200775 and compound-2 (10.1038/S41386-018-0213-7 )
- 5ZG3: crystal structure of the glua2o lbd in complex with glutamate and tak- 137 (10.1038/S41386-018-0213-7 )
- 6DLZ: open state glua2 in complex with stz after micelle signal subtraction (10.1016/J.NEURON.2018.07.027 )
- 6DM0: open state glua2 in complex with stz and blocked by iem-1460, after micelle signal subtraction (10.1016/J.NEURON.2018.07.027 )
- 6DM1: open state glua2 in complex with stz and blocked by naspm, after micelle signal subtraction (10.1016/J.NEURON.2018.07.027 )
- 6FAZ: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the positive allosteric modulator tdpam01 at 1.4 a resolution. (10.1021/ACS.JMEDCHEM.8B00250 )
- 6FQG: glua2(flop) g724c ligand binding core dimer bound to l-glutamate (form a) at 2.34 angstrom resolution
- 6FQH: glua2(flop) s729c ligand binding core dimer bound to nbqx at 1.76 angstrom resolution (10.1038/S41467-019-12280-9 )
- 6FQI: glua2(flop) g724c ligand binding core dimer bound to l-glutamate (form b) at 2.91 angstrom resolution (10.1038/S41467-019-12280-9 )
- 6FQJ: glua2(flop) g724c ligand binding core dimer bound to zk200775 at 2.50 angstrom resolution (10.1038/S41467-019-12280-9 )
- 6FQK: glua2(flop) s729c ligand binding core dimer bound to zk200775 at 1.98 angstrom resolution (10.1038/S41467-019-12280-9 )
- 6GIV: structure of glua2-n775s ligand-binding domain (s1s2j) in complex with glutamate and rubidium bromide at 1.75 a resolution (10.1016/J.NEURON.2019.03.046 )
- 6GL4: structure of glua2o ligand-binding domain (s1s2j) in complex with glutamate and sodium bromide at 1.95 a resolution (10.1016/J.NEURON.2019.03.046 )
- 6HC9: structure of glua2 ligand-binding domain (s1s2j-l504y-n775s) in complex with glutamate and tdpam02 at 2.4 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
- 6HCA: structure of glua2 ligand-binding domain (s1s1j) in complex with positive allosteric modulator tdpam02 at 1.8 a resolution (10.1021/ACSMEDCHEMLETT.8B00369 )
- 6HCB: structure of glua2 ligand-binding domain (s1s2j-n775s) in complex with glutamate and tdpam01 at 1.9 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
- 6HCC: structure of glua2 ligand-binding domain (s1s2j-n775s) in complex with glutamate and tdpam02 at 1.6 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
- 6HCH: structure of glua2 ligand-binding domain (s1s2j-l504y-n775s) in complex with glutamate and tdpam01 at 1.6 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
- 6NJL: structure of a complex (10.1126/SCIENCE.AAW8250 )
- 6NJM: structure of a complex (10.1126/SCIENCE.AAW8250 )
- 6NJN: structure of a complex (10.1126/SCIENCE.AAW8250 )
- 6O9G: open state glua2 in complex with stz and blocked by agtx-636, after micelle signal subtraction (10.1016/J.NEURON.2018.07.027 )
- 6PEQ: glua2 in complex with its auxiliary subunit cnih3 - map lbd-tmd-c3 - with antagonist zk200775 -without ntd (10.1126/SCIENCE.AAY2783 )
- 6Q54: structure of glua2 ligand-binding domain (s1s2j) in complex with the agonist (s)-2-amino-3-(1-ethyl-4-hydroxy-1h-1,2,3-triazol-5-yl) propanoic acid at 1.4 a resolution (10.1021/ACS.JMEDCHEM.8B01986 )
- 6Q60: structure of glua2 ligand-binding domain (s1s2j) in complex with the agonist (s)-2-amino-3-(2-methyl-5-hydroxy-2h-1,2,3-triazol-4-yl) propanoic acid at 1.55 a resolution (10.1021/ACS.JMEDCHEM.8B01986 )
- 6QKC: glua1/2 in complex with auxiliary subunit gamma-8 (10.1126/SCIENCE.AAV9011 )
- 6QKZ: full length glua1/2-gamma8 complex (10.1126/SCIENCE.AAV9011 )
- 6RUQ: structure of glua2cryst in complex the antagonist zk200775 and the negative allosteric modulator gyki53655 at 4.65 a resolution (10.1111/FEBS.15455 )
- 6U5S: ntd of glua2 in complex with cnih3 - with antagonist zk200775 - in pseudo-symmetric global conformation (10.1126/SCIENCE.AAY2783 )
- 6U6I: ntd of glua2 in complex with cnih3 - with antagonist zk200775 - in asymmetric global conformation (10.1126/SCIENCE.AAY2783 )
- 6UCB: glua2 in complex with its auxiliary subunit cnih3 - with antagonist zk200775, lbd, tmd, cnih3, and lipids (10.1126/SCIENCE.AAY2783 )
- 6UD4: glua2 in complex with its auxiliary subunit cnih3 in as map ii - (lbd- tmd-c3(as) ii)- with antagonist zk200775, without ntd (10.1126/SCIENCE.AAY2783 )
- 6UD8: glua2 in complex with its auxiliary subunit cnih3 - with antagonist zk200775 (10.1126/SCIENCE.AAY2783 )
- 6XSR: crystal structure of glua2 ampa receptor in complex with trans-4- butylcyclohexane carboxylic acid (4-bcca) inhibitor (10.1111/BPH.15254 )
- 6YK2: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound (s)-1-[2'-amino-2'-carboxyethyl]-5,7- dihydrothieno[3,4-d]pyrimidin- 2,4(1h,3h)-dione at resolution 1.60a (10.1021/ACSCHEMNEURO.0C00195 )
- 6YK3: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound ( s) - 1- [2'-amino-2'-carboxyethyl]-5 ,7- dihydropyrrolo[3,4-d]pyrimidin-2,4(1h,3h)-dione at resolution 1.20a (10.1021/ACSCHEMNEURO.0C00195 )
- 6YK4: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound ( s) - 1- [2'-amino-2'-carboxyethyl]-6- methyl-5 ,7- dihydropyrrolo[3,4-d]pyrimidin-2,4(1h,3h)-dione at resolution 1.00a (10.1021/ACSCHEMNEURO.0C00195 )
- 6YK5: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound (s)-1-(2'-amino-2'-carboxyethyl)-5,7- dihydrofuro[3,4-d]- pyrimidine-2,4(1h,3h)-dione at resolution 1.15a (10.1021/ACSCHEMNEURO.0C00195 )
- 6YK6: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound (s)-1-(2'-amino-2'-carboxyethyl)furo[3,4- d]pyrimidin-2,4-dione at resolution 1.47a (10.1021/ACSCHEMNEURO.0C00195 )